Anlotinib plus penpulimab significantly improved progression-free survival and overall survival versus sorafenib in unresectable HCC and might be a new first-line option. These findings require ...

Systemic treatment is a main way for pancreas cancer patients that are ineligible for surgery. A subgroup of patients showed good response to systemic treatment and the rest received limited benefits.

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Locoregional therapies play a fundamental role in the treatment of patients with early and intermediate and locally advanced hepatocellular carcinomas. With encouraging recent advances in ...

Dr. Charles D. Neblett, co-founder of the SNCC Freedom Singers and civil rights icon. Neblett is currently battling stage 4 prostate cancer while leading the national Black Prostate Check Challenge™ ...

Common indications for the use of systemic therapy, including terbinafine, ketoconazole, itraconazole, fluconazole and griseofulvin, in children and young adults are reviewed.

Guselkumab, risankizumab, tildrakizumab, ixekizumab, and ustekinumab have superior safety profiles for the treatment of psoriasis compared with adalimumab, whereas dimethyl fumarate and infliximab ...

The patented and patent-pending innovations are in the fields of cancer treatments and freshwater management. The fund is managed by the Purdue Innovates Incubator, which provides programming for the ...

ObjectivesRituximab (RTX) has been commonly used for the treatment of patients with severe or refractory systemic lupus erythematosus (SLE), yet real-world d ...

Systemic thalidomide and low-dose methotrexate have beneficial effects. In cases of recalcitrant skin lesions, treatment often comprises oral corticosteroids alongside vinblastine; however, the ...